DAVOS, Switzerland (Reuters) – Chief executives are more worried than a year ago about the global economic outlook, as deflation stalks Europe and commodity prices wilt, but the United States stands out as a bright spot.
That is the verdict of a worldwide survey of more than 1,300 CEOs, released on the eve of the Jan. 21-24 World Economic Forum annual meeting in Davos, that also found business leaders still moderately confident in their own firms’ ability to grow revenues.
DAVOS, Switzerland (Reuters) – As the world’s business and political elite ascends the Swiss Alps for an annual bout of crystal-ball gazing this week, history suggests the Davos pundits are likely to get plenty of things wrong.
More than 1,500 business leaders and 40 heads of state or government will attend the Jan. 21-24 meeting of the World Economic Forum (WEF) to network and discuss big themes, from the price of oil to the future of the Internet.
LONDON (Reuters) – GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this offers value to shareholders.
Chief Executive Andrew Witty told Reuters the group’s large consumer health business would be more viable as a standalone operation following the conclusion of a $20 billion asset swap with Novartis NOVN.VX, especially if it bought additional assets.